The mission of the Data Science and Information Technology Program (DSITP) is to develop an enterprise-level, consolidated information technology infrastructure that provides exceptional IT capabilities to the Frederick National Labs for Cancer Research (NCI-Frederick/FNLCR) in support of basic, translational, and clinical cancer and AIDS research. The Biomedical Informatics Applications Development (BIAD)Group is part of the DSITP within Leidos Biomedical Research. The BIAD team is primarily involved in the development of the projects sponsored by NCI. Currently BIAD is developing the following high visibility projects NCI MATCH https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/nci-match
, Pediatric MATCH https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/pediatric-match
and NCI CTRP https://www.cancer.gov/about-nci/organization/ccct/ctrp
This position will be responsible for supporting the Biomedical applications being developed for NCI.
The Bioinformatics Analyst IV will be part of a fast-paced, cross-functional team of biologists, bioinformaticians and software developers working at the leading edge of Precision Medicine.
The Bioinformatics Analyst IV:
Will maintain and extend existing bioinformatics workflows to meet the changing needs of current biomedical applications
Will design, develop and deploy robust high-throughput, genomic data processing and analysis pipelines
Will develop accurate, thorough and timely clinical reports for our stakeholders
Mentor and supervise junior colleagues on coding, data processing and data analysis
Is expected to be proficient with Python, Perl, and the Linux command line
Requires a strong knowledge of bioinformatics file types including, but not limited to, VCF, FASTA/FASTQ, SAM/BAM, BED
Requires a strong knowledge of next generation sequencing (NGS), variant annotation, and variant calling pipelines
To be considered for this position, you must minimally meet the knowledge, skills, and abilities listed below:
Possession of a Bachelor's degree (Master's degree preferred) in biomedical science/bioinformatics/math/computer related field from an accredited college or university according to the Council for Higher Education Accreditation (CHEA) (Additional qualifying experience may be substituted for the required education).
Foreign degrees must be evaluated for U.S. equivalency
In addition to educational requirements, a minimum of eight (8) years of progressively responsible relevant experience
Must be able to obtain and maintain a security clearance
Candidates with these desired skills will be given preferential consideration:
Previous work with Clinical trials
Experience with ThermoFisher Ion Reporter
Adept at scripting languages: Perl, Python
A deep understanding of NGS data processing and analysis
Experience in Variant Analysis
Knowledge of variant databases: COSMIC, dbSNP, ClinVar
Leidos is a global science and technology solutions leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company’s 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended January 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems & Global Solutions business (IS&GS). For more information, visit www.Leidos.com. The company’s diverse employees support vital missions for government and commercial customers. Qualified women, minorities, individuals with disabilities and protected veterans are encouraged to apply. Leidos will consider qualified applicants with criminal histories for employment in accordance with relevant Laws. Leidos is an Equal Opportunity Employer.
Website : http://www.leidos.com
We bring a mix of innovative technology and sector expertise to customers in national security, health, and infrastructure. We look for solutions that not only transform businesses, but change the world.